Corvus Pharmaceuticals
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
863 Mitten Rd Ste 102, Burlingame, Calif...Phone Number
(650) 900-4520Website
www.corvuspharma.comRevenue
-Stock Symbol
CRVSIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
3
1
1
1
1
About Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted oncology therapies. Corvus focuses on bringing medicines to patients with the most difficult-to-treat cancers. Corvus is headquartered in Burlingame, California.Explore more
Corvus Pharmaceuticals Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Corvus Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Corvus Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Corvus Pharmaceuticals launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Corvus Pharmaceuticals
Click to see if Corvus Pharmaceuticals had a recent Job posting/layoffs
Earning: See what the market has to say on Corvus Pharmaceuticals recently announced quarterly report
Check out if Corvus Pharmaceuticals is spiking on competitors!
Funding: Get notified immidiatlly once Corvus Pharmaceuticals has new funding data
Check if Corvus Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Corvus Pharmaceuticals as Masked Content
Find 3 more new buyers
Compare Similar Companies to Corvus Pharmaceuticals
Compare insights from companies similar to Corvus Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Corvus Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Corvus Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Corvus Pharmaceuticals.
Corvus Pharmaceuticals financials insights
Gather financial insights about Corvus Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Series A
$33.5M
2015
Series B
$75M
2016
Stock Offering
$71M
2018
Stock Offering
$64.8M
Corvus Pharmaceuticals Tech Stack
A closer look at the technologies used by Corvus Pharmaceuticals
See more technologies
Most Recent Scoops
Hiring Plans
Corvus Pharmaceuticals has more open roles in Operations than it has had at any time in the past 12 months. Areas of expertise include: Project Management, Organizing Meetings, and Administrative Support.
Hiring Plans
Person-Based
Medical Research, Pharmaceuticals
Person-Based
Events, Finance, Investor Relations
Open Position
Open Position
Corvus Pharmaceuticals News & Media
Boxer Capital’s $18 Million Corvus Pharma Bet Signals Confidence in This Biotech’s Next Phase
Corvus Pharmaceuticals develops immuno-oncology therapies, advancing clinical candidates for cancer and immune-related conditions.Corvus Pharmaceuticals, Inc. (CRVS) Shareholder/Analyst Call Transcript
Corvus Pharmaceuticals, Inc. (CRVS) Shareholder/Analyst Call May 14, 2026 1:30 PM EDTCompany ParticipantsRichard Miller - Co-Founder, President, CEO &...Corvus Pharmaceuticals Presents Soquelitinib Phase 1 Atopic Dermatitis Data at the Society for Investigative Dermatology (SID) Annual Meeting
New immunologic and biomarker data supports the potential of ITK inhibition with soquelitinib to increase persistent Treg cells and influence multiple inflammatory pathways.Corvus Pharmaceuticals Appoints Andrew C. Chan, M.D., Ph.D., to Board of Directors
SOUTH SAN FRANCISCO, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, announced today that Andrew C. Chan, M.D., Ph.D., has been appointed to the Company’s Board of Directors. Dr. Chan recently served as Senior Vice President, Research Biology during a distinguished 25 year career at Genentech. In this role, he led biological research across all therapeutic areas, contributing to the development of several FDA-app
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Corvus Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted oncology therapies. Corvus focuses on bringing medicines to patients with the most difficult-to-treat cancers. Corvus is headquartered in Burlingame, California.... Read More
